Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)

科研成果: 工作论文

205 下载量 (Pure)

摘要

During the 2022 session of “two meetings”, rare diseases have been cited as one of the focus in healthcare in Prime Minister working report2. It is an important recognition of the severity of the issue and the need to find practical solutions. This article summarizes the situation of drugs against rare diseases in China and the progress already done. Moving forward, it suggests upgrading their positioning in the healthcare strategy in order to solve an important social issue and bring more steam into innovation in pharmaceutical.
源语言英语
出版状态已出版 - 3月 2022

Source

China Europe International Business School (CEIBS)

指纹

探究 'Rare Diseases Are Not Rare in China: What can be done more for this Special Category of Patients (CEIBS Working Paper, No. 046/2022/MKT/POM, 2022)' 的科研主题。它们共同构成独一无二的指纹。

引用此